Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Impact of Experience on Results With the Third Eye Retroscope
NCT00969124 · View on ClinicalTrials.gov ↗
Study Summary
The Third Eye Retroscope is a device that can be used with a colonoscope to improve the ability of a physician to see areas of the colon that may be hidden from the view of the colonoscope. Previous studies have shown that physicians are able to detect additional polyps when they use the device along with the colonoscope. The purpose of this study is to determine whether physicians can detect greater numbers of additional polyps as they gain in experience with the device.
Conditions Studied
Interventions
- DEVICE Third Eye Retroscope
Study Locations (9)
Texas
- Parkland Hospital — Dallas
- Baylor University Medical Center — Dallas
- S.W. Fort Worth Endoscopy Center — Fort Worth
- North Hills Hospital — North Richland Hills
Illinois
- University of Chicago — Chicago
- NorthShore University HealthSystem — Evanston
Florida
- Florida Hospital — Celebration
Massachusetts
- University of Massachusetts — Worcester
Minnesota
- Hennepin County Medical Center — Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00969124
The ClinicalTrials.gov registry entry for NCT00969124 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avantis Medical Systems, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Colorectal Neoplasms appearing as the primary indexed condition, and to 1 intervention — of which Third Eye Retroscope is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT00969124 reports 9 study locations spanning 5 distinct geographic areas — top geographies include Texas, Illinois, Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT00969124 about?
NCT00969124 is a clinical study titled "Impact of Experience on Results With the Third Eye Retroscope". The Third Eye Retroscope is a device that can be used with a colonoscope to improve the ability of a physician to see areas of the colon that may be hidden from the view of the colonoscope. Previous studies have shown that physicians are able to detect additional polyps when they use the device alo...
What is the current status of trial NCT00969124?
This trial is currently completed. It is a NA study. The enrollment target is 328 participants. The study started on 2009-01. Estimated completion is 2009-10.
What conditions does trial NCT00969124 study?
This clinical trial studies the following conditions: Colorectal Neoplasms. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT00969124?
The interventions under investigation include: Third Eye Retroscope (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT00969124?
This trial is sponsored by Avantis Medical Systems, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT00969124 being conducted?
This trial has 9 study locations across Florida, Illinois, Massachusetts, Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.